Quarter Period Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7373032

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Quarter period statement of income
Statement of income
Net sales
54,937,000,000 JPY
49,093,000,000 JPY
Cost of sales
31,292,000,000 JPY
27,481,000,000 JPY
Gross profit (loss)
23,645,000,000 JPY
21,611,000,000 JPY
Selling, general and administrative expenses
22,500,000,000 JPY
20,833,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
1,144,000,000 JPY
777,000,000 JPY
Non-operating income
Interest income
17,000,000 JPY
2,000,000 JPY
Dividend income
251,000,000 JPY
236,000,000 JPY
Non-operating income
313,000,000 JPY
447,000,000 JPY
Non-operating expenses
Interest expenses
33,000,000 JPY
34,000,000 JPY
Non-operating expenses
70,000,000 JPY
53,000,000 JPY
Ordinary profit (loss)
1,387,000,000 JPY
1,171,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
0 JPY
Extraordinary income
969,000,000 JPY
1,319,000,000 JPY
Extraordinary losses
Impairment losses
JPY
101,000,000 JPY
Extraordinary losses
8,000,000 JPY
678,000,000 JPY
Profit (loss) before income taxes
2,349,000,000 JPY
1,812,000,000 JPY
Income taxes
591,000,000 JPY
569,000,000 JPY
Profit (loss)
1,757,000,000 JPY
1,242,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.